- Home
- SCLX vs WBX Comparison
SCLX vs WBX Comparison
Compare SCLX & WBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- WBX
- Stock Information
- Founded
- SCLX 2011
- WBX 2015
- Country
- SCLX United States
- WBX Spain
- Employees
- SCLX N/A
- WBX N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- WBX Industrial Specialties
- Sector
- SCLX Health Care
- WBX Consumer Discretionary
- Exchange
- SCLX Nasdaq
- WBX Nasdaq
- Market Cap
- SCLX 139.3M
- WBX 118.0M
- IPO Year
- SCLX N/A
- WBX N/A
- Fundamental
- Price
- SCLX $15.30
- WBX $3.42
- Analyst Decision
- SCLX Hold
- WBX Buy
- Analyst Count
- SCLX 1
- WBX 4
- Target Price
- SCLX N/A
- WBX $9.50
- AVG Volume (30 Days)
- SCLX 140.1K
- WBX 31.5K
- Earning Date
- SCLX 08-13-2025
- WBX 11-05-2025
- Dividend Yield
- SCLX N/A
- WBX N/A
- EPS Growth
- SCLX N/A
- WBX N/A
- EPS
- SCLX N/A
- WBX N/A
- Revenue
- SCLX $40,360,000.00
- WBX $193,321,600.00
- Revenue This Year
- SCLX $89.26
- WBX N/A
- Revenue Next Year
- SCLX $203.95
- WBX $46.25
- P/E Ratio
- SCLX N/A
- WBX N/A
- Revenue Growth
- SCLX N/A
- WBX 127.17
- 52 Week Low
- SCLX $3.60
- WBX $3.26
- 52 Week High
- SCLX $34.27
- WBX $15.00
- Technical
- Relative Strength Index (RSI)
- SCLX 42.42
- WBX 24.42
- Support Level
- SCLX $17.28
- WBX $4.64
- Resistance Level
- SCLX $19.56
- WBX $4.28
- Average True Range (ATR)
- SCLX 1.97
- WBX 0.31
- MACD
- SCLX -0.02
- WBX -0.12
- Stochastic Oscillator
- SCLX 3.68
- WBX 10.71
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.